Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 13, 2018

App aims to improve inhaler technique for patients on Fostair

Chiesi, the UK and Ireland affiliate of Italian pharmaceutical company Chiesi Farmaceutici, has announced the launch of a mobile app for adult asthma or chronic obstructive pulmonary disease (COPD) patients who use Fostair or Fostair NEXThaler inhalers.

By Charlotte Edwards

Chiesi, the UK and Ireland affiliate of Italian pharmaceutical company Chiesi Farmaceutici, has announced the launch of a mobile app for adult asthma or chronic obstructive pulmonary disease (COPD) patients who use Fostair or Fostair NEXThaler inhalers.

The app has been designed to aid healthcare professionals in improving the device technique and medication adherence of their adult patients with asthma or COPD. It is not intended to completely replace the advice of healthcare professionals.

Chiesi wants the app to tackle the common problem of inefficient inhalation technique by patients who forget how to use their inhalers correctly. Inhaler misuse increases the risk of hospitalisation, emergency hospital visits, courses of oral steroids and poor disease control.

Inefficient inhalation has been identified as a barrier to effective asthma care and contributes to uncontrolled asthma, mortality and morbidity, impaired quality of life, exacerbations and urgent health care interventions.

To help improve adherence, the Chiesi Respiratory Patient Support app allows patients to record their inhaler technique and compare it to videos of best practice, rate their technique and then share the findings with a healthcare professional. Patients can also opt to receive dose reminders, log when doses have been taken and achieve ‘milestones’ if they successfully take their medication over consecutive days. They can also receive daily motivational messages.

Chiesi UK managing director Tom Delahoyde said: “Our aim is to help healthcare professionals to better support patients in achieving the desired outcome from their Fostair treatment. With this in mind, we have designed an app which aims to support healthcare professionals with patient inhaler technique training.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

“The importance of treatment adherence is well-established and if we can play a role in helping patients to use their inhalers as prescribed by their healthcare professional, we hope to make a real impact on their lives. We are very excited to bring this new tool to patients and their healthcare professionals and plan to update it following feedback from clinicians and patients.”

The app can be downloaded from http://www.chiesirespiratory.co.uk as well as the App Store and Google Play.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU